Showing 6,921 - 6,940 results of 7,713 for search '"United States"', query time: 0.19s Refine Results
  1. 6921
  2. 6922
  3. 6923

    «THE CONSCIENCE OF THE WORLD» OR «CONSPIRACY OF SILENCE»? TO THE ANNIVERSARIES OF THE EVIAN AND BERMUDA CONFERENCES by D. V. Ivanov, A. V. Krylov, V. M. Morozov, V. O. Pechatnov, S. A. Sklyarov, E. O. Shebalina

    Published 2018-09-01
    “…The author concludes that the unpreparedness of European states and the United States to accept ethnic Jews from German-occupied countries on their territory became one of the reasons for their mass death. …”
    Get full text
    Article
  4. 6924

    Availability and Key Characteristics of National Early Warning Systems for Emerging Profiles of Antimicrobial Resistance in High-Income Countries: Systematic Review by Jessica Iera, Claudia Isonne, Chiara Seghieri, Lara Tavoschi, Mariateresa Ceparano, Antonio Sciurti, Alessia D'Alisera, Monica Sane Schepisi, Giuseppe Migliara, Carolina Marzuillo, Paolo Villari, Fortunato D'Ancona, Valentina Baccolini

    Published 2025-01-01
    “…ResultsWe identified 7 national EWSs from 72 high-income countries: 2 in the East Asia and Pacific Region (Australia and Japan), 3 in Europe and Central Asia (France, Sweden, and the United Kingdom), and 2 in North America (the United States and Canada). The systems were established quite recently; in most cases, they covered both community and hospital settings, but their main characteristics varied widely across countries in terms of the organization and microorganisms under surveillance, with also different definitions of emerging AMR and alert functioning. …”
    Get full text
    Article
  5. 6925

    Hospital frailty risk score predicts graft failure severe infection and mortality in hospitalized kidney transplant recipients from 2010 to 2018 US data by Lumin Chen, Feifan Chu, Hangbin Ma, Zujie Chen, Yuning Ma, Qiwei Ji, Hao Zhou

    Published 2025-02-01
    “…In this retrospective observational study, we extracted data on 185,742 patients from the National Inpatient Sample (NIS) database in the United States. The patients were further separated into three groups based on the HFRS. …”
    Get full text
    Article
  6. 6926
  7. 6927
  8. 6928

    Effects of Reduced Substrate Volumetric Water Contents on the Morphology and Physiology of Three Landscape Shrubs Grown in a Greenhouse by Ji-Jhong Chen, Youping Sun

    Published 2025-01-01
    “…Many cities in the western United States now mandate the incorporation of drought-tolerant plants in new landscapes because of concerns regarding water scarcity. …”
    Get full text
    Article
  9. 6929
  10. 6930
  11. 6931
  12. 6932
  13. 6933

    A Machine Learning Algorithm to Predict Medical Device Recall by the Food and Drug Administration by Victor Barbosa Slivinskis, Isabela Agi Maluli, Joshua Seth Broder

    Published 2024-11-01
    “…Identification of dangerous medical devices as early as possible is necessary to minimize patient harms while avoiding false positives to prevent removal of safe devices from use. While the United States Food and Drug Administration (FDA) employs an adverse event reporting program (MedWatch) and database (MAUDE), other data sources and methods might have utility to identify potentially dangerous medical devices. …”
    Get full text
    Article
  14. 6934

    Unveiling Sociocultural Barriers to Breast Cancer Awareness Among the South Asian Population: Case Study of Bangladesh and West Bengal, India by Fahmida Hamid, Tania Roy

    Published 2025-01-01
    “…For the broader South Asian population, this figure is 16%, while it is 11% in the United States and the United Kingdom. These statistics highlight the need for an urgent investigation into the reasons behind these regions’ late diagnoses and treatment. …”
    Get full text
    Article
  15. 6935
  16. 6936

    Reversal gene expression assessment for drug repurposing, a case study of glioblastoma by Shixue Sun, Zeenat Shyr, Kathleen McDaniel, Yuhong Fang, Dingyin Tao, Catherine Z. Chen, Wei Zheng, Qian Zhu

    Published 2025-01-01
    “…Furthermore, none of the United States Food and Drug Administration (FDA) approved drugs used for GBM deliver satisfactory survival improvement. …”
    Get full text
    Article
  17. 6937
  18. 6938
  19. 6939
  20. 6940